Basic information
Biomarker: COX-2
Histology type: rare type
Cohort characteristics
Country: Israel
Region: Tel Aviv
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
27 | carcinosarcoma | 27 |
Sample information
Conclusion: In view of the role of COX-2 in carcinogenesis, our finding that COX-2 expression may confer a better survival in patients with carcinosarcoma is intriguing. Larger studies are indicated to elucidate the effect of COX-2 expression on survival in patients with carcinosarcoma because this may have therapeutic implications.
Sample type : tissue
Sample method: immunohistochemical staining
Expression pattern : expression(high staining score)
Expression elevation: Cyclooxygenase-2 immunohistochemical staining of more than 10% of the cells was considered positive. The staining was assessed by the pathologists according to two parameters: the evaluated intensity of staining and the proportion of cytoplasmic stained cells. Staining of more than 10% of the cells was considered positive. The staining intensity was graded on a 0–3 scale, in which 0 represents no detectable staining, and 1, 2 and 3 represent faint, moderate and intense staining, respectively. A scoring index was then calculated by multiplying the intensity grade by the percentage of stained cells. The score was considered low when the index was equal or less than 1 and high when it was more than 1.
Disease information
Related information
Funtion Uniprot: Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix.
UniProt ID: P00403
UniProt Link: https://www.uniprot.org/uniprotkb/P00403/entry
Biological function from UniProt: #Electron transport #Respiratory chain #Transport
Molecular function from UniProt:
Subcellular UniProt: #Membrane #Mitochondrion #Mitochondrion inner membrane
Alternative name from UniProt:
Catalytic activity: 4 Fe(II)-[cytochrome c] + 8 H+(in) + O2 = 4 Fe(III)-[cytochrome c] + 4 H+(out) + 2 H2O,This reaction proceeds in the forward direction.
Recommended name: Cytochrome c oxidase subunit 2
Gene name from HGNC: MT-CO2 (CO2, COX2, MTCO2)
HPA class: Disease related genes Enzymes Human disease related genes Metabolic proteins Potential drug targets Transporters
AlphaFold DB: P00403
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P00403
HPA link: https://www.proteinatlas.org/ENSG00000198712-MT-CO2
Tissue specificity RNA from HPA: Tissue enhanced (brain, heart muscle)
Tissue expression from HPA: Ubiquitous cytoplasmic expression with a granular pattern.
Single cell type specificity Cell type enriched (Cardiomyocytes)
Immune cell specificity: Low immune cell specificity
Cancer prognostic summary HPA Prognostic marker in liver cancer (favorable) and pancreatic cancer (favorable)
Pathology link: https://www.proteinatlas.org/ENSG00000198712-MT-CO2/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000198712-MT-CO2/pathology/endometrial+cancer
Phenotype ID: 220110;
Disease: Mitochondrial complex IV deficiency (MT-C4D)
Note1: The disease is caused by variants affecting the gene represented in this entry
OMIM: 516040
OMIM link1: https://www.omim.org/entry/220110
OMIM link2: https://www.omim.org/entry/516040
HGNC ID: HGNC:7421
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7421